Medtronic PLC: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Medtronic PLC Unternehmen

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Unternehmensinformationen

Unternehmens-codeMDT

Name des UnternehmensMedtronic PLC

IPO-datumNov 21, 1977

Gegründet am2014

CEOMr. Geoffrey S. (Geoff) Martha

Anzahl der mitarbeiter95000

WertpapierartOrdinary Share

GeschäftsjahresendeNov 21

AddresseBuilding Two Parkmore Business Park West

StadtDUBLIN

BörseNYSE Consolidated

LandIreland

PostleitzahlH91 4K49

Telefon1135314381700

Websitehttps://www.medtronic.com/

Unternehmens-codeMDT

IPO-datumNov 21, 1977

Gegründet am2014

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.03M

+0.45%

Mr. Sean M. Salmon

Executive Vice President and President - Cardiovascular Portfolio

543.91K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

486.64K

-0.61%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

111.10K

+90.72%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Ms. Denise M. O'Leary

Independent Director

48.75K

+0.66%

Mr. Kendall J. (Ken) Powell

Independent Director

46.09K

+2.03%

Mr. Michael Marinaro

Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit

39.00K

-1.45%

Mr. Craig Arnold

Lead Independent Director

38.30K

+0.19%

Mr. Thierry Jean Louis Pieton

Chief Financial Officer, Executive Vice President

30.75K

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Geoffrey S. (Geoff) Martha

Executive Chairman of the Board, Chief Executive Officer

1.03M

+0.45%

Mr. Sean M. Salmon

Executive Vice President and President - Cardiovascular Portfolio

543.91K

-0.12%

Mr. Brett A. Wall

Executive Vice President and President - Neuroscience Portfolio

486.64K

-0.61%

Mr. Gregory L. Smith

Executive Vice President - Global Operations and Supply Chain

111.10K

+90.72%

Mr. Ivan K. Fong

Executive Vice President, General Counsel, Corporate Secretary

52.34K

-6.34%

Ms. Denise M. O'Leary

Independent Director

48.75K

+0.66%

Umsatzaufteilung

Währung: USDUpdate-Zeit: Sun, Apr 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Surgical & Endoscopy

1.60B

19.25%

Cardiac Rhythm & Heart Failure

1.54B

18.63%

Cranial & Spinal Technologies

1.25B

15.07%

Structural Heart & Aortic

874.00M

10.54%

Specialty Therapies

732.00M

8.83%

Other

2.29B

27.68%

Nach RegionUSD

Name

Umsatz

Anteil

United States

4.24B

51.10%

Rest of World

4.03B

48.56%

Ireland

28.00M

0.34%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Surgical & Endoscopy

1.60B

19.25%

Cardiac Rhythm & Heart Failure

1.54B

18.63%

Cranial & Spinal Technologies

1.25B

15.07%

Structural Heart & Aortic

874.00M

10.54%

Specialty Therapies

732.00M

8.83%

Other

2.29B

27.68%

Aktionäre

Update-Zeit: Sat, Apr 26

Aktionärsstatistik

Art

Aktionärsstatistik

Aktionäre

Anteil

The Vanguard Group, Inc.

9.64%

BlackRock Institutional Trust Company, N.A.

5.31%

State Street Global Advisors (US)

4.71%

Capital Research Global Investors

2.59%

Geode Capital Management, L.L.C.

2.11%

Other

75.64%

Aktionärsstatistik

Aktionäre

Anteil

The Vanguard Group, Inc.

9.64%

BlackRock Institutional Trust Company, N.A.

5.31%

State Street Global Advisors (US)

4.71%

Capital Research Global Investors

2.59%

Geode Capital Management, L.L.C.

2.11%

Other

75.64%

Art

Aktionäre

Anteil

Investment Advisor/Hedge Fund

39.50%

Investment Advisor

34.70%

Research Firm

3.70%

Pension Fund

2.38%

Bank and Trust

2.17%

Hedge Fund

2.15%

Sovereign Wealth Fund

1.22%

Insurance Company

0.39%

Individual Investor

0.25%

Other

13.53%

Institutionelle Beteiligung

Update-Zeit: Thu, Feb 20

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q1

3733

1.12B

87.34%

+5.03M

2024Q4

3768

1.12B

87.17%

+3.13M

2024Q3

3708

1.10B

85.63%

-24.55M

2024Q2

3725

1.11B

86.25%

-54.16M

2024Q1

3789

1.14B

85.95%

-7.87M

2023Q4

3780

1.13B

85.36%

-20.57M

2023Q3

3761

1.14B

85.37%

-14.93M

2023Q2

3764

1.13B

85.01%

-24.32M

2023Q1

3738

1.14B

85.40%

-14.71M

2022Q4

3689

1.13B

84.79%

-25.98M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

123.63M

9.64%

+776.44K

+0.63%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

68.04M

5.31%

+1.54M

+2.32%

Dec 31, 2024

State Street Global Advisors (US)

60.44M

4.71%

-293.90K

-0.48%

Dec 31, 2024

Capital Research Global Investors

33.20M

2.59%

+571.70K

+1.75%

Dec 31, 2024

Geode Capital Management, L.L.C.

27.06M

2.11%

+574.05K

+2.17%

Dec 31, 2024

JP Morgan Asset Management

24.34M

1.9%

+2.87M

+13.36%

Dec 31, 2024

MFS Investment Management

19.23M

1.5%

-3.64M

-15.91%

Dec 31, 2024

DWS Investment GmbH

14.66M

1.14%

+197.49K

+1.37%

Dec 31, 2024

Norges Bank Investment Management (NBIM)

14.57M

1.14%

-1.01M

-6.49%

Dec 31, 2024

BlackRock Financial Management, Inc.

13.22M

1.03%

+764.34K

+6.14%

Dec 31, 2024

Verbundene ETFs

Update-Zeit: Sun, Apr 6

Name

Anteil

Absolute Select Value ETF

6.39%

Polen Capital International Growth ETF

5.81%

Cullen Enhanced Equity Income ETF

5.03%

Madison Dividend Value ETF

4.07%

iShares U.S. Medical Devices ETF

4.01%

Madison Covered Call ETF

3.98%

American Century Focused Large Cap Value ETF

3.84%

First Trust Active Global Quality Income ETF

3.64%

JPMorgan Healthcare Leaders ETF

3.28%

USCF Dividend Income Fund

3.2%

Absolute Select Value ETF

Anteil6.39%

Polen Capital International Growth ETF

Anteil5.81%

Cullen Enhanced Equity Income ETF

Anteil5.03%

Madison Dividend Value ETF

Anteil4.07%

iShares U.S. Medical Devices ETF

Anteil4.01%

Madison Covered Call ETF

Anteil3.98%

American Century Focused Large Cap Value ETF

Anteil3.84%

First Trust Active Global Quality Income ETF

Anteil3.64%

JPMorgan Healthcare Leaders ETF

Anteil3.28%

USCF Dividend Income Fund

Anteil3.2%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 16.68B USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Mar 06, 2025

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Apr 11, 2025 going ex on Mar 28, 2025 with reinvestment option

Mar 28, 2025

Apr 11, 2025

Mar 28, 2025

Dec 05, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option

Dec 27, 2024

Jan 10, 2025

Dec 27, 2024

Aug 16, 2024

MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option

Sep 27, 2024

Oct 11, 2024

Sep 27, 2024

May 23, 2024

MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option

Jun 28, 2024

Jul 12, 2024

Jun 28, 2024

Mar 07, 2024

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option

Mar 22, 2024

Apr 12, 2024

Mar 21, 2024

Dec 07, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023

Dec 20, 2023

Jan 12, 2024

Dec 19, 2023

Aug 17, 2023

MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option

Sep 22, 2023

Oct 13, 2023

Sep 21, 2023

May 25, 2023

MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option

Jun 23, 2023

Jul 14, 2023

Jun 22, 2023

Mar 02, 2023

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023

Mar 24, 2023

Apr 14, 2023

Mar 23, 2023

Dec 08, 2022

MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022

Dec 21, 2022

Jan 13, 2023

Dec 20, 2022

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Medtronic PLC

83.871USD

Medtronic PLC

83.871

Übersicht

Unternehmen